The linear no-threshold relationship is inconsistent with radiation biologic and experimental data

Radiology

Volumn 251, Issue 1, 2009, Pages 13-22

  Tubiana, Maurice ^a   Feinendegen, Ludwig E ^b   Yang, Chichuan ^c   Kaminski, Joseph M ^d  

^a Centre Antoine Beclere   (France)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c American Radiology Services   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ARTICLE; ATOMIC BOMB; BYSTANDER EFFECT; CANCER RISK; CARCINOGENESIS; CELL PROTECTION; CHERNOBYL ACCIDENT; DEFENSE MECHANISM; DNA REPAIR; DOSE RESPONSE; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HORMESIS; HUMAN; IONIZING RADIATION; LINEAR NO THRESHOLD MODEL; OCCUPATIONAL EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PROTECTION; RISK ASSESSMENT; STATISTICAL MODEL; AIR POLLUTION; BODY BURDEN; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; INCIDENCE; METHODOLOGY; NOTE; PROPORTIONAL HAZARDS MODEL; RADIATION INJURY; RADIATION RESPONSE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS;

AIR POLLUTION, RADIOACTIVE; BODY BURDEN; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; LINEAR MODELS; NEOPLASMS, RADIATION-INDUCED; PROPORTIONAL HAZARDS MODELS; RADIATION DOSAGE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 64949191402     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2511080671     Document Type: Article

References (167)

1. Rothkamm K, Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003;100(9):5057-5062. (Pubitemid 36542657)
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57-70. (Pubitemid 30046295)
3. Weinberg RA. The biology of cancer. New York, NY: Taylor & Francis, 2006.
4. Park CC, Henshall-Powell RL, Erickson AC, et al. Ionizing radiation induces heritable disruption of epithelial cell interactions. Proc Natl Acad Sci U S A 2003;100(19):10728-10733.
5. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10(8):789-799. (Pubitemid 39070849)
6. Trosko JE, Chang CC, Upham BL, Tai MH. Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann N Y Acad Sci 2004;1028:192-201. (Pubitemid 40361822)
7. Kathren RL. Pathway to a paradigm: the linear non-threshold dose-response model in historical context. The American Academy of Health Physics 1995;Radiology Centennial Hartman Oration. Health Phys 1996;70(5):621-635.
8. Berrington de González A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004;363(9406):345- 351. (Pubitemid 38169539)
9. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007;357(22):2277-2284. (Pubitemid 350190758)
10. Tubiana M, Aurengo A, Averbeck D, et al, eds. Dose-effect relationships and the estimation of the carcinogenic effects of low doses of ionizing radiation. Academy of Medicine (Paris) and Academy of Science (Paris) Joint Report No. 2, March 30, 2005.
11. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from low levels of ionizing radiation: BEIR VII, Phase 2. Washington, DC: The National Academies Press, 2006.
12. International Commission on Radiological Protection. Low-dose extrapolation of radiation-related cancer risk. Publication 99. Amsterdam, the Netherlands: Elsevier, 2006.
13. De Bont R, Van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 2004;19(3):169-185. (Pubitemid 38744825)
14. Spitz DR, Azzam EI, Li JJ, Gius D. Cancer Metastasis Rev 2004;23(3-4):311-322.
15. Burkart W, Jung T, Frasch G. Damage pattern as a function of radiation quality and other factors. C R Acad Sci III 1999;322(2-3):89-101.
16. Tubiana M. The linear no-threshold relationship and advances in our understanding of carcinogenesis. Int J Low Radiat 2008;5(3):173-204.
17. Zahradka K, Slade D, Bailone A, et al. Reassembly of shattered chromosomes in Deinococcus radiodurans. Nature 2006;443(7111):569-573.
18. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39-85. (Pubitemid 39050363)
19. Shiloh Y, Lehmann AR. Maintaining integrity. Nat Cell Biol 2004;6(10):923-928. (Pubitemid 39359844)
20. Bakkenist CJ, Kastan MB. Initiating cellular stress responses. Cell 2004;118(1):9-17. (Pubitemid 38902810)
21. Dikomey E, Brammer I. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal fibroblast line. Int J Radiat Biol 2000;76(6):773-781. (Pubitemid 30352760)
22. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double strand break repair pathway choice. Cell Res 2008;18(1):134-147.
23. Zha S, Alt FW, Cheng HL, Brush JW, Li G. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proc Natl Acad Sci U S A 2007;104(11):4518-4523. (Pubitemid 47186257)
24. Tong WM, Cortes U, Hande MP, et al. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res 2002;62(23):6990-6996.
25. Boucher D, Hindo J, Averbeck D. Increased repair of gamma-induced DNA double-strand breaks at lower dose-rate in CHO cells. Can J Physiol Pharmacol 2004;82(2):125-132. (Pubitemid 38534719)
26. Rothkamm K, Löbrich M. Misrepair of radiation-induced DNA double-strand breaks and its relevance for tumorigenesis and cancer treatment (review). Int J Oncol 2002;21(2):433-440.
27. Löbrich M, Jeggo PA. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 2007;7(11):861-869. (Pubitemid 350006255)
28. Krueger SA, Joiner MC, Weinfeld M, Piasentin E, Marples B. Role of apoptosis in low-dose hyper radiosensitivity. Radiat Res 2007;167(3):260-267.
29. Vilenchik MM, Knudson AG. Inverse radiation dose-rate effects on somatic and germline mutations and DNA damage rates. Proc Natl Acad Sci U S A 2000;97(10):5381-5386. (Pubitemid 30313727)
30. Vilenchik MM, Knudson AG. Endogenous DNA double-strand break production, fidelity of repair and induction of cancer. Proc Natl Acad Sci U S A 2003;100(22):12871-12876. (Pubitemid 37339992)
31. Hooker AM, Bhat M, Day TK, et al. The linear no-threshold model does not hold for low-dose ionizing radiation. Radiat Res 2004;162(4):447-452.
32. Zeng G, Day TK, Hooker AM, et al. Nonlinear chromosomal inversion response in prostate after low dose X-radiation exposure. Mutat Res 2006;602(1-2):65-73.
33. Loucas BD, Eberle R, Bailey SM, Cornforth MN. Influence of dose rate on the induction of simple and complex chromosome exchanges by gamma rays. Radiat Res 2004;162(4):339-349. (Pubitemid 39388155)
34. UNSCEAR: United Nations Scientific Committee on the effects of atomic radiation. Sources, effects and risks of ionising radiation. New York, NY: United Nations, 2000.
35. Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys 2004;58(2):410-419. (Pubitemid 38142466)
36. Krueger SA, Collis SJ, Joiner MC, Wilson GD, Marples B. Transition in survival from low dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser 1981 activity. Int J Radiat Oncol Biol Phys 2007;69(4):1262-1271.
37. Löbrich M, Kühne M, Wetzel J, Rothkamm K. Joining of correct and incorrect double-strand break ends in normal human and ataxia telangiectasia fibroblasts. Genes Chromosomes Cancer 2000;27(1):59-68.
38. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984;5(4):453-458. (Pubitemid 14126708)
39. Columbano A, Endoh T, Denda A, et al. Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis 1996;17(3):395-400.
40. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000;29(3-4):323-333.
41. Collis SJ, Schwaninger JM, Ntambi AJ, et al. Evasion of early cellular response mechanisms following low level radiation induced DNA damage. J Biol Chem 2004;279(48):49624-49632.
42. Löbrich M, Rief N, Kühne M, et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci U S A 2005;102(25):8984-8989.
43. Bartkova J, Rezaei N, Liontos M, et al. Oncogene induced senescence is part of the tumorigenesis barrier imposed by the DNA damage checkpoints. Nature 2006;444(7119):633-637.
44. Campisi J. Senescent cells, tumor suppression and organism aging. Cell 2005;120(4):513-522.
45. Schmitt CA. Cellular senescence and cancer treatment. Biochim Biophys Acta 2007;1775(1):5-20.
46. Feinendegen LE, Pollycove M. Biologic responses to low doses of ionizing radiation: detriment versus hormesis. I. Dose responses of cells and tissues. J Nucl Med 2001;42(7):17N-27N.
47. Rigaud O, Moustacchi E. Radioadaptation for gene mutation and the possible molecular mechanisms of the adaptive response. Mutat Res 1996;358(2):127-134. (Pubitemid 26384282)
48. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ Health Perspect 1998;106(suppl 1):277-283.
49. Broome EJ, Brown DL, Mitchel RE. Dose responses for adaption to low dose of (60)Co gamma rays and (3)H beta particles in normal human fibroblasts. Radiat Res 2002;158(2):181-186.
50. Portess DI, Bauer G, Hill MA, O'Neill P. Low-dose irradiation on nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 2007;67(3):1246-1253. (Pubitemid 46270784)
51. Bauer G. Low dose radiation and intercellular induction of apoptosis: potential implications for the control of oncogenesis. Int J Radiat Biol 2007;83(11-12):873-888. (Pubitemid 350219109)
52. Day TK, Zeng G, Hooker AM, et al. Adaptive response for chromosomal inversions on pKZ1 mouse prostate induced by low doses of X radiation delivered after a high dose. Radiat Res 2007;167(6):682-692.
53. Barquinero JF, Barrios L, Caballin MR, et al. Occupational exposure to radiation induces an adaptive response in human lymphocytes. Int J Radiat Biol 1995;67(2):187-191.
54. Stoilov LM, Mullenders LH, Darroudi F, Natarajan AT. Adaptive response to DNA and chromosomal damage induced by Xrays in human blood lymphocytes. Mutagenesis 2007;22(2):117-122. (Pubitemid 46364517)
55. Ghiassi-nejad M, Mortazavi SM, Cameron JR, Niroomand-rad A, Karam PA. Very high background radiation areas of Ramsar, Iran: preliminary biological studies. Health Phys 2002;82(1):87-93. (Pubitemid 33152074)
56. Mothersill C, Seymour CB. Radiation-induced bystander effects and the DNA paradigm: an "out of field" perspective. Mutat Res 2006;597(1-2):5-10.
57. Belyakov OV, Folkard M, Mothersill C, Prise KM, Michael BD. Bystander induced differentiation: a major response to targeted irradiation of a urothelial explant model. Mutat Res 2006;597(1-2):43-49.
58. Schettino G, Folkard M, Michael BD, Prise KM. Low-dose binary behavior of bystander cell killing after microbeam irradiation of a single cell with focused c(k) x rays. Radiat Res 2005;163(3):332-336. (Pubitemid 40293542)
59. Smith RW, Wang J, Bucking CP, Mothersill CE, Seymour CB. Evidence for a protective response by the gill proteome of rainbow trout exposed to X-ray induced bystander signals. Proteomics 2007;7(22):4171-4180. (Pubitemid 350190288)
60. Carnes BA, Groer PG, Kotek TJ. Radium dial workers: issues concerning dose response and modeling. Radiat Res 1997;147(6):707-714.
61. van Kaick G, Dalheimer A, Hornik S, et al. The German Thorotrast Study: recent results and assessment of risks. Radiat Res 1999;152(6 suppl):S64-S72.
62. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation. I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 2003;159(5):567-580.
63. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumors. Trends Cell Biol 1999;9(12):M57-M61. (Pubitemid 30009427)
64. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 1999;96(26):15121-15126.
65. Streffer C. Bystander effects, adaptive response and genomic instability induced by prenatal irradiation. Mutat Res 2004;568(1):79-87. (Pubitemid 39458298)
66. Kadhim MA, Hill MA, Moore SR. Genomic instability and the role of radiation quality. Radiat Prot Dosimetry 2006;122(1-4):221-227. (Pubitemid 47090455)
67. Okada M, Okabe A, Uchihori Y, et al. Single extreme low dose/low dose rate irradiation causes alteration in lifespan and genome instability in primary human cells. Br J Cancer 2007;96(11):1707-1710.
68. Boulton E, Cleary H, Papworth D, Plumb M. Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. Int J Radiat Biol 2001;77(1):21-29. (Pubitemid 32096693)
69. Bhowmick NA, Chytil A, Plieth D, et al. TGF-beta signalling in fibroblasts modulates the oncogenic potential of adjacent epithelium. Science 2004;303(5659):848-851.
70. Radisky DC, Bissell MJ. Cancer: respect thy neighbor! Science 2004;303(5659):775-777.
71. Radisky ES, Radisky DC. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord 2007;8(3):279-287. (Pubitemid 47524870)
72. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4(11):839-849. (Pubitemid 39472951)
73. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117(5):1175-1183. (Pubitemid 46718402)
74. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000;60(5):1254-1260. (Pubitemid 30151992)
75. Barcellos-Hoff MH. Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage. Semin Cancer Biol 2005;15(2):138-148. (Pubitemid 40126245)
76. Jaffe LF. Epigenetic theories of cancer initiation. Adv Cancer Res 2003;90:209-230. (Pubitemid 37549226)
77. Pardoll DM. Immunology: stress, NK receptors, and immune surveillance. Science 2001;294(5542):534-536. (Pubitemid 32999541)
78. Feinendegen LE, Pollycove M, Neumann RD. Whole body responses to low-level radiation exposure: new concepts in mammalian radiobiology. Exp Hematol 2007;35(4 suppl 1):37-46. (Pubitemid 46427981)
79. Mantovani A, Romero P, Palucka AK, Marincola FM. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 2008;371(9614):771-783.
80. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348(17):1681-1691. (Pubitemid 36459475)
81. Liu SZ. Cancer control related to stimulation of immunity by low dose irradiation. Dose Response 2006;5(1):39-47.
82. Amundson SA, Lee RA, Koch-Paiz CA, et al. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res 2003;1(6):445-452.
83. Mercier G, Berthault N, Mary J, Peyre J, et al. Biological detection of low radiation doses by combining results of two microarray analysis methods. Nucleic Acids Res 2004;32(1):e12.
84. Franco N, Lamartine J, Frouin V, et al. Low-dose exposure to gamma rays induces specific gene regulations in normal human keratinocytes. Radiat Res 2005;163(6):623-635.
85. Sokolov MV, Smirnova NA, Camerini-Otero RD, Neumann RD, Panyutin IG. Microarray analysis of differentially expressed genes after exposure of normal human fibroblasts to ionizing radiation from an external source and from DNA-incorporated iodine-125 radionuclide. Gene 2006;382:47-56. (Pubitemid 44550245)
86. Yang F, Stenoien DL, Strittmatter EF, et al. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J Proteome Res 2006;5(5):1252-1260.
87. Duport P. A database of cancer induction by low dose radiation in mammals: overview and initial observations. Int J Low Radiat 2003;1(1):120-131.
88. Calabrese EJ. Hormesis: from marginalization to mainstream-a case for hormesis as the default dose-response model in risk assessment. Toxicol Appl Pharmacol 2004;197(2):125-136. (Pubitemid 38639903)
89. Feinendegen LE. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 2005;78(925):3-7. (Pubitemid 40277127)
90. Azzam EI, de Toledo SM, Raaphorst GP, Mitchell RE. Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2. Radiat Res 1996;146(4):369-373. (Pubitemid 26332768)
91. Redpath JL. Radiation induced neoplastic transformation in vitro: evidence for a protective effect at low doses of low LET. Cancer Metastasis Rev 2004;23(3-4):333-339. (Pubitemid 38881816)
92. Ko M, Lao XY, Kapadia R, Elmore E, Redpath JL. Neoplastic transformation in vitro by low doses of ionizing radiation: role of adaptive response and bystander effects. Mutat Res 2006;597(1-2):11-17.
93. Elmore E, Lao XY, Kapadia R, Redpath JL. The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat Res 2006;166(6):832-838.
94. Kaiser J. Hormesis: a healthful dab of radiation? Science 2003;302(5644):378.
95. Feinendegen LE, Neumann RD. Physics must join with biology in better assessing risk from low dose irradiation. Radiat Prot Dosimetry 2005;117(4):346-356.
96. Jeggo P, Löbrich M. Radiation-induced DNA damage responses. Radiat Prot Dosimetry 2006;122(1-4):124-127. (Pubitemid 47090437)
97. Tanooka H. Threshold dose-response in radiation carcinogenesis: an approach from chronic beta-irradiation experiments and a review of non tumour doses. Int J Radiat Biol 2001;77(5):541-551. (Pubitemid 32436777)
98. Little MP, Wakeford R, Tawn EJ, Bouffler SD, Berrington de Gonzalez A. Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology 2009;251(1):6-12.
99. Little MP, Muirhead CR. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int J Radiat Biol 1996;70(1):83-94. (Pubitemid 26253640)
100. Little MP, Muirhead CR. Derivation of low dose extrapolation factors from analysis of the curvature in the cancer incidence dose response in Japanese atomic bomb survivors. Int J Radiat Biol 2000;76(7):939-953. (Pubitemid 30446957)
101. Preston DL, Pierce DA, Shimizu Y, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 2004;162(4):377-389.
102. Preston DL, Ron E, Tokuoka S, et al. Solid tumors incidence in atomic bomb survivors 1958-1998. Radiat Res 2007;168(1):1-64.
103. Suit H, Goldberg S, Niemierko A, et al. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 2007;167(1):12-42.
104. Heidenreich WF, Paretzke HG, Jacob P. No evidence for increased tumour rates below 200 mSv in atomic bomb survivors. Radiat Environ Biophys 1997;36(3):205-207.
105. Breckow J. Linear-no-threshold is a radiation-protection standard rather than a mechanistic effect model. Radiat Environ Biophys 2006;44(4):257-260. (Pubitemid 43326059)
106. Kellerer AM, Nekolla E. Neutrons versus gamma ray risk estimates: inferences from the cancer incidence and mortality data in Hiroshima. Radiat Environ Biophys 1997;36(2):73-83. (Pubitemid 27353730)
107. Walsh L, Rhum W, Kellerer AM. Cancer risk estimates for gamma rays with regard to organ specific dose: all solid cancer combined. Radiat Environ Biophys 2004;43(3):145-151. (Pubitemid 39592779)
108. Samet JM, Geyh AS, Utell MJ. The legacy of World Trade Center dust. N Engl J Med 2007;356(22):2233-2236. (Pubitemid 46849152)
109. Moline J, Herbert R, Nguyen N. Health consequences of the September 11 World Trade Center attacks: a review. Cancer Invest 2006;24(3):294-301.
110. Ma F, Fleming LE, Lee DJ, Trapido E, Gerace TA. Cancer incidence in Florida professional firefighters, 1981 to 1999. J Occup Environ Med 2006;48(9):883-888.
111. LeMasters GK, Genaidy AM, Succop P, et al. Cancer risk among firefighters: a review and meta-analysis of 32 studies. J Occup Environ Med 2006;48(11):1189-1202.
112. Kang D, Davis LK, Hunt P, Kriebel D. Cancer incidence among male Massachusetts firefighters 1987-2003. Am J Ind Med 2008;51(5):329-335.
113. Bates MN. Registry-based case-control study of cancer in California firefighters. Am J Ind Med 2007;50(5):339-344. (Pubitemid 46786851)
114. Guidotti TL. Evaluating causality for occupational cancers: the example of firefighters. Occup Med (Lond) 2007;57(7):466-471. (Pubitemid 47517018)
115. Youakim S. Risk of cancer among firefighters: a quantitative review of selected malignancies. Arch Environ Occup Health 2006;61(5):223-231. (Pubitemid 47425161)
116. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997;70:130-139. (Pubitemid 27091013)
117. Shu XO, Potter JD, Linet MS, et al. Diagnostic X rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype. Cancer Epidemiol Biomarkers Prev 2002;11(2):177-185.
118. International Agency for Research on Cancer. Monograph on the evaluation of carcinogenic risks to humans. Vol.75, Ionizing radiation, part I: X and gamma radiation and neutrons. Lyon, France: International Agency for Research on Cancer, 2000.
119. Naumburg E, Bellocco R, Cnattingius S, Hall P, Boice JD Jr, Ekbom A. Intrauterine exposure to diagnostic X rays and risk of childhood leukemia subtypes. Radiat Res 2001;156(6):718-723. (Pubitemid 34024266)
120. Inskip PD, Harvey EB, Boice JD, et al. Incidence of cancer in twins. Cancer Causes Control 1991;2(5):315-324.
121. Rodvall Y, Hrubec Z, Pershagen G, Ahlbom A, Bjurman A, Boice JD Jr. Childhood cancer among Swedish twins. Cancer Causes Control 1992;3(6):527-532.
122. Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. Cancer mortality among atomic bomb survivors exposed in utero or as young children. Radiat Res 1997;147(3):385-395.
123. Cardis E, Howe G, Ron E, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006;26(2):127-140.
124. Cardis E, Kesminienne A, Ivanov V, et al. Risk of thyroid cancer after exposure to I-131 in childhood. J Natl Cancer Inst 2005;97(10):724-732.
125. Scott BR. Re: Risk of thyroid cancer after exposure to (131)I in childhood. J Natl Cancer Inst 2006;98(8):561; author reply 561.
126. Doll R, Berrington A, Darby SC. Low mortality of British radiologists. Br J Radiol 2005;78(935):1057-1058. (Pubitemid 41684038)
127. Cameron JR. Radiation increased the longevity of British radiologists. Br J Radiol 2002;75(895):637-639.
128. Mohan AK, Hauptmann M, Freedman DM, et al. Cancer and other causes of mortality among radiologic technologists in the United States. Int J Cancer 2003;103(2):259-267.
129. Sigurdson AJ, Doody MM, Rao RS, et al. Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 2003;97(12):3080-3089.
130. Blettner M, Zeeb H, Auvinen A, et al. Mortality from cancer and other causes among male airline cockpit crew in Europe. Int J Cancer 2003;106(6):946-952.
131. Cardis E, Gilbert ES, Carpenter L, et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995;142(2):117-132.
132. Cardis E, Vrijheid M, Blettner M, et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 2007;167(4):396-416.
133. Zablotska LB, Ashmore JP, Jowe GR. Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat Res 2004;161(6):633-641. (Pubitemid 39149571)
134. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation. II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 2003;159(5):581-596.
135. Hill C, Laplanche A. Overall mortality and cancer mortality around French nuclear sites. Nature 1990;347(6295):755-757. (Pubitemid 20370719)
136. Wheldon TE, Mairs RJ, Barret A. Causality of relationship between paternal radiation exposure and leukaemia incidence in the children of Sellafield workers. Int J Radiat Biol 1992;61(5):565-566.
137. Darby SC, Doll R. Fallout, radiation doses near Dounreay, and childhood leukaemia. Br Med J (Clin Res Ed) 1987;294(6572):603-607. (Pubitemid 17028140)
138. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 1988;2(8624):1323-1327. (Pubitemid 19004433)
139. Boutou O, Guisard AV, Slama R, et al. Population mixing and leukaemia in young people around the La Hague nuclear waste processing plant. Br J Cancer 2002;87(7):740-745.
140. Evrard AS, Hemon D, Morin A, et al. Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates. Br J Cancer 2006;94(9):1342-1347.
141. Rudant J, Baccaini B, Ripert M, et al. Population-mixing at the place of residence at the time of birth and incidence of childhood leukaemia in France. Eur J Cancer 2006;42(7):927-933.
142. Nair MK, Nambi KS, Amma NS, et al. Population study in the high natural background radiation area in Kerala, India. Radiat Res 1999;152(6 suppl):S145-S148.
143. Tao Z, Zha Y, Akiba S, et al. Cancer mortality in the high background radiation areas of Yangjiang, China during the period between 1979 and 1995. J Radiat Res (Tokyo) 2000;41(suppl):31-41.
144. Hayata I, Wang C, Zhang W, et al. Effect of high level natural radiation on chromosomes of residents in southern China. Cytogenet Genome Res 2004;104(1-4):237-239.
145. Boice JD Jr, Morin MM, Glass AG, et al. Diagnostic X-ray procedures and risk of leukemia, lymphoma and multiple myeloma. JAMA 1991;265(10):1290-1294.
146. Linos A, Gray JE, Orvis AL, et al. Low dose radiation and leukemia. N Engl J Med 1980; 302(20):1101-1115.
147. Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006;36(suppl 14):121-125. (Pubitemid 44145197)
148. Boice JD, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125(2):214-222.
149. Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989;321(19):1285-1289.
150. Morin Doody M, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE. Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine 2000;25(16):2052-2063.
151. Tubiana M. Computed tomography and radiation exposure [letter]. N Engl J Med 2008;358(8):850; author reply 852-853.
152. Nagataki S. Computed tomography and radiation exposure [letter]. N Engl J Med 2008;358(8):850-851; author reply 852-853.
153. Feinendegen LE. Computed tomography and radiation exposure [letter]. N Engl J Med 2008;358(8):851; author reply 852-853.
154. Rubino C, de Vathaire F, Shamsaldin A, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003;89(5):840-846. (Pubitemid 37175805)
155. Tubiana M, Aurengo A, Masse R, Valleron AJ. Risk of cancer from diagnostic X-rays. Lancet 2004;363(9424):1908.
156. Little MP. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with cancer risks observed in the Japanese A-bomb survivors. Int J Radiat Biol 2001;77(4):431-464. (Pubitemid 32281126)
157. Le Pogam MA, Rubino C, Diallo I, et al. Radiation dose fractionation and second cancer risks after breast cancer treatment. Radiat Prot Dosimetry [in press].
158. Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996;38(3):269-271. (Pubitemid 26079444)
159. Lundell M, Mattsson A, Karlsson P, Holmberg E, Gustafsson A, Holm LE. Breast cancer risk after radiotherapy in infancy. Radiat Res 1999;151(5):626-632.
160. Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer incidence after localized therapy for prostate. Cancer 2006;107(5):991-998. (Pubitemid 44291148)
161. Rubino C, Adjadj E, Doyon F, et al. Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma. Int J Radiat Oncol Biol Phys 2005;62(4):1084-1089.
162. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population based study. Lancet 1999;353(9170):2111-2115. (Pubitemid 29278480)
163. de Vathaire F. Données épidémiologiques sur les effets cancérigènes des faibles doses de rayonnements ionisants. Annexe 4. Relation dose-effet et l'estimation des effets cancérogè nes des faibles doses de rayonnements ionisants. Rapport Conjoint no2, Acad Sc et Acad Med (version Française). Nucleon édition-Paris 2005; 147-168.
164. Walinder G. Has radiation protection become a health hazard? The Swedish Nuclear Training and Safety Centre, Nykoping, Sweden. Madison, Wis: Med Phys Publishing, 1995;16-63, 95-117, 128-137.
165. Wigg DR. Radiation: facts, fallacies, and phobias. Australas Radiol 2007;51(1):21-25.
166. Taubes G. Epidemiology faces its limits. Science 1995;269(5221):164-169.
167. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997;13(10):410-414.